ACE2	Angiotensin-converting enzyme 2
ANB	Antiviral neutralization bioassay
AUC	Area Under the Curve
AUCFPR	Area Under the Curve Restricted to The False Positive Rates
BS	Biosensors
CI	Confidence interval
CLIA	Chemiluminescence immunoassay
CMIA	Chemiluminescent microparticle immunoassay
COVID-19	Coronavirus disease
CRISPR	Clustered regularly interspaced short palindromic repeats
DOR	Diagnostic Likelihood Ratio
ECLIA	Electrochemiluminescence immunoassay
ELISA	Enzyme-Linked Immunosorbent Assay
FIA	Fluorescence immunoassay
FN	False negatives
FP	False positives
IgA	Immunoglobulin A
IgG	Immunoglobulin G
IgM	Immunoglobulin M
INPLASY	International Platform of Registered Systematic Review and Meta-analysis Protocols
LFIA	Lateral flow immunoassay
LR−	Negative Likelihood Ratio
LR+	Positive Likelihood Ratio
MA	Microarrays
MeSH	Medical Subject Headings
NCBI	National Center for Biotechnology Information
NGS	Next-generation sequencing
PRISMA	Preferred Reporting Items for Systematic Reviews and Meta-Analyses
PRNT	Plaque Reduction Neutralization Test
ROC	Receiver Operating Characteristics
RT-LAMP	Reverse transcriptase loop-mediated isothermal amplification
RT-PCR	Reverse transcription–polymerase chain reaction
SARS-CoV-2	Severe acute respiratory syndrome coronavirus 2
Se	Sensibility
Sp	Specificity
sROC	Summary Receiver Operating Characteristics
TN	True negatives
TP	True positives
WHO	World Health Organization